RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$9.76B
AUM Growth
+$1.65B
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
88
New
Increased
Reduced
Closed

Top Buys

1
+$114M
2
+$105M
3
+$72M
4
PRAX icon
Praxis Precision Medicines
PRAX
+$69.6M
5
EVMN
Evommune Inc
EVMN
+$65M

Top Sells

1
+$292M
2
+$141M
3
+$55.5M
4
BLTE
Belite Bio
BLTE
+$52.4M
5
DNTH icon
Dianthus Therapeutics
DNTH
+$48.7M

Sector Composition

1 Healthcare 99.82%
2 Financials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ASND icon
1
Ascendis Pharma
ASND
$14.3B
$2.19B 22.46%
10,281,496
CDTX
2
DELISTED
Cidara Therapeutics
CDTX
$743M 7.62%
3,365,523
RYTM icon
3
Rhythm Pharmaceuticals
RYTM
$6.19B
$714M 7.31%
6,666,837
+985,478
RNAM
4
Avidity Biosciences
RNAM
$11.2B
$623M 6.39%
8,641,031
PCVX icon
5
Vaxcyte
PCVX
$8.86B
$495M 5.07%
10,724,599
-1,241,392
SION
6
Sionna Therapeutics
SION
$1.63B
$407M 4.17%
9,905,045
-540,277
NAMS icon
7
NewAmsterdam Pharma
NAMS
$4.08B
$335M 3.43%
9,550,191
-588,747
TYRA icon
8
Tyra Biosciences
TYRA
$1.78B
$321M 3.29%
12,198,625
WVE icon
9
Wave Life Sciences
WVE
$2.59B
$309M 3.17%
18,203,009
+1,000
MLYS icon
10
Mineralys Therapeutics
MLYS
$2.32B
$266M 2.72%
7,323,750
EWTX icon
11
Edgewise Therapeutics
EWTX
$3.22B
$259M 2.65%
10,428,437
SEPN
12
Septerna Inc
SEPN
$1.3B
$195M 2%
6,995,858
NUVL icon
13
Nuvalent
NUVL
$7.92B
$189M 1.94%
1,880,057
+633,601
IRON icon
14
Disc Medicine
IRON
$2.51B
$157M 1.61%
1,976,132
+399,026
JANX icon
15
Janux Therapeutics
JANX
$819M
$154M 1.58%
11,189,693
PEPG icon
16
PepGen
PEPG
$428M
$131M 1.34%
20,064,545
TSHA icon
17
Taysha Gene Therapies
TSHA
$1.24B
$130M 1.33%
23,555,648
SPRY icon
18
ARS Pharmaceuticals
SPRY
$917M
$127M 1.3%
10,860,977
BCRX icon
19
BioCryst Pharmaceuticals
BCRX
$2.17B
$123M 1.26%
+15,827,186
BCAX
20
Bicara Therapeutics
BCAX
$919M
$117M 1.2%
6,955,993
PRAX icon
21
Praxis Precision Medicines
PRAX
$9.34B
$110M 1.13%
+373,787
GHRS icon
22
GH Research
GHRS
$921M
$97.5M 1%
7,676,697
GERN icon
23
Geron
GERN
$1.07B
$84.2M 0.86%
63,771,366
+3,392,000
ACLX icon
24
Arcellx
ACLX
$6.58B
$82.6M 0.85%
1,267,156
-1,769,371
CLYM
25
Climb Bio
CLYM
$488M
$77.7M 0.8%
11,293,828
-20,125,439
1
2 3 4